|
JMY expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02529999999701E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.35939999987589E-07 |
| Normal-vs-Stage2 |
1.361850E-01 |
| Normal-vs-Stage3 |
1.351790E-01 |
| Normal-vs-Stage4 |
7.830200E-01 |
| Stage1-vs-Stage2 |
2.143200E-01 |
| Stage1-vs-Stage3 |
2.154000E-01 |
| Stage1-vs-Stage4 |
4.417800E-01 |
| Stage2-vs-Stage3 |
9.118400E-01 |
| Stage2-vs-Stage4 |
7.274200E-01 |
| Stage3-vs-Stage4 |
7.667000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48019999999904E-05 |
| Normal-vs-AfricanAmerican |
3.378300E-04 |
| Normal-vs-Asian |
6.816400E-01 |
| Caucasian-vs-AfricanAmerican |
9.003200E-01 |
| Caucasian-vs-Asian |
4.442800E-01 |
| AfricanAmerican-vs-Asian |
3.825600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82069999965506E-07 |
| Normal-vs-Female |
3.273400E-01 |
| Male-vs-Female |
1.758490E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.235400E-03 |
| Normal-vs-Extreme_Weight |
3.01270000058196E-08 |
| Normal-vs-Obese |
2.155900E-02 |
| Normal-vs-Extreme_Obese |
9.68810000000486E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.906800E-01 |
| Normal_Weight-vs-Obese |
3.806800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.602800E-01 |
| Extreme_Weight-vs-Obese |
1.191930E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.076000E-01 |
| Obese-vs-Extreme_Obese |
1.390820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.332000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.958600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.00750000015171E-07 |
| Normal-vs-Age(81-100Yrs) |
4.259200000023E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.921000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.433800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.248100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.949800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.000080E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.936000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63284999999957E-05 |
| Normal-VS-Type2 PRCC |
9.35599999696279E-08 |
| Normal-VS-KIRP CIMP |
9.966000E-02 |
| Normal-VS-Unclassified PRCC |
2.339600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.355600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.045800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.410800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.073970E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.589600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.002140E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.29409999999985E-05 |
| Normal-vs-N1 |
5.828400E-01 |
| Normal-vs-N2 |
7.834800E-01 |
| N0-vs-N1 |
1.906110E-02 |
| N0-vs-N2 |
4.913400E-01 |
| N1-vs-N2 |
7.237400E-01 |
|
|
